The Implementation Guide is a resource for implementing this program. It provides important information about the staffing and functions necessary for administering this program in the user's setting. Additionally, the steps needed to carry out the research-tested program, relevant program materials, and information for evaluating the program are included. The Implementation Guide can be viewed and downloaded in the Products page.
The PSA Test for Prostate Cancer: Is it Right for ME?
|Program Title||The PSA Test for Prostate Cancer: Is it Right for ME?|
|Purpose||Designed to enhance knowledge and increase patient participation in the decision making process for prostate cancer screening. (2004)|
|Program Focus||Awareness building and Behavior Modification|
|Topic||Informed Decision Making, Prostate Cancer Screening|
|Age||This information has not been reported.|
|Gender||This information has not been reported.|
|Race/Ethnicity||This information has not been reported.|
|Setting||This information has not been reported.|
|Funded by||VA Health Services Research and Development (Grant number(s): 11R99277-1)|
|User Reviews||(Be the first to write a review for this program)|
The intended audience is males who are eligible for prostate cancer screening. Evaluation study participants were male veterans ages 50 years and older who had no prostate cancer and scheduled primary care appointments at one of four Veterans Affairs medical facilities in the Midwest. Approximately 80% of the participants finished high school; 95% were White. Other participants were Alaskan Native, American Indian, Black, and Hispanic.
893 men from four Midwestern Veteran Affairs medical facilities were randomly assigned to: 1) a comparison group that received usual care; 2) a pamphlet group; or 3) a video group. One week prior to a scheduled appointment with their primary care provider, participants were mailed a pamphlet or video, depending on the arm to which they were assigned. The pamphlet, written at a 6th grade-reading level, defined the prostate-specific antigen (PSA) test, and described the prostate and prostate cancer. Discussion about the accuracy of the PSA and the unknown efficacy of prostate cancer treatments provided readers with reasons why some doctors do not recommend the test. Video participants received a 23-minute video developed by the Foundation for Informed Medical Decision Making. Similar to the pamphlet, the video provided viewers with a balanced representation of the risks and benefits of screening. Participants were surveyed by phone approximately one week after their primary care appointments. PSA testing rates were assessed at 2 weeks and 1 year after primary care appointments, by examining records and procedural code information obtained through the Veterans Affairs' databases.
- Pamphlet and video participants scored moderately higher than the control group on the mean knowledge index.
- Differences between pamphlet and video scores were not statistically significant.
- Pamphlet and video participants scored higher on individual knowledge questions on prostate cancer natural history, treatment efficacy, and expert disagreement about PSA testing.
- Pamphlet but not video participants were more likely to discuss screening with their primary care provider than control group participants.
- Participants who received the pamphlet and participants who received the video were less likely to intend to have a PSA, relative to the controls.
(Be the first to write a review for this program)